Evidence map›Paper›PMID 38379900›Full record

ArticleFrontiers in pharmacology2024

Clinical characteristics and risk factors analysis of 505 cases of infusion reactions in a tertiary hospital.

Weiwei Yin, Bingqin Wen, Guoan Wang, Zhipeng Wang, Xuetao Kong, Yaozhou Wu, Xiao Meng, Xinyi Ou, Li Wei, Pengjiu Yu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Weiwei Yin *Department of Pharmacy, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Bingqin Wen *Department of Pharmacy, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Guoan WangSchool of Pharmaceutical Science, Guangzhou Medical University, Guangzhou, China.
Zhipeng WangDepartment of Pharmacy, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Xuetao KongNational Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China.
Yaozhou WuDepartment of Pharmacy, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Xiao MengDepartment of Pharmacy, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Xinyi OuDepartment of Pharmacy, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Li WeiDepartment of Pharmacy, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Pengjiu YuDepartment of Pharmacy, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Guangzhou Medical University · CNFirst Affiliated Hospital of Guangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical characteristicsinfusion reactionspharmacovigilancerisk factorstertiary hospital

Identifiers

PMID38379900
PMCPMC10876897
OpenAlexW4391573964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.